7-iodo-8-hydroxy-3-methyl-1-(4-azidophenyl)-2,3,4,5-tetrahydro-1H-3-benzazepine: structure given in first source; 125I-labeled cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 3082777 |
| CHEMBL ID | 434215 |
| MeSH ID | M0162691 |
| Synonym |
|---|
| i(125)-mab |
| 116234-50-5 |
| (+-)-5-(4-azidophenyl)-2,3,4,5-tetrahydro-8-iodo-3-methyl-1h-3-benzazepin-7-ol |
| 7-iodo-8-hydroxy-3-methyl-1-(4'-azidophenyl)-2,3,4,5-tetrahydro-1h-benzazepine |
| 1h-3-benzazepin-7-ol, 5-(4-azidophenyl)-2,3,4,5-tetrahydro-8-iodo-3-methyl-, (+-)- |
| 7-iodo-8-hydroxy-3-methyl-1-(4-azidophenyl)-2,3,4,5-tetrahydro-1h-3-benzazepine |
| imab |
| CHEMBL434215 , |
| 5-(4-azidophenyl)-8-iodo-3-methyl-1,2,4,5-tetrahydro-3-benzazepin-7-ol |
| 5-(4-azido-phenyl)-8-iodo-3-methyl-2,3,4,5-tetrahydro-1h-benzo[d]azepin-7-ol |
| bdbm50022817 |
| DTXSID20921980 |
| 5-(4-azidophenyl)-8-iodo-3-methyl-2,3,4,5-tetrahydro-1h-3-benzazepin-7-ol |
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID63206 | Ability to inhibit the binding of [3H]-SCH- 23390 to canine striatal membrane | 1988 | Journal of medicinal chemistry, Nov, Volume: 31, Issue:11 | A photoaffinity label for the D-1 dopamine receptor, (RS)-7-[125I]Iodo-8-hydroxy-3-methyl-1-(4'-azidophenyl)-2,3,4,5- tetrahydro-1H-3-benzazepine, selectively identifies the ligand binding subunits of the receptor. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 3 (50.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.50) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 6 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||